Peter Clapp
Overview
Explore the profile of Peter Clapp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kennedy D, Clapp P, DeLuca J, Filtz T, Kroon L, Lamberts J, et al.
Am J Pharm Educ
. 2021 Sep;
86(5):8764.
PMID: 34507961
To explore methods that pharmacy programs can use to redefine their work environment to reduce stress, improve well-being, and increase faculty productivity. To demonstrate a culture of support, organizations should...
2.
Janke K, Bechtol R, James S, Lepp G, Moote R, Clapp P
Am J Pharm Educ
. 2019 Dec;
83(9):7109.
PMID: 31871344
To determine the indicators of quality for application activities in pharmacy team-based learning (TBL). A modified Delphi process was conducted with pharmacy TBL experts. Twenty-three experts met the inclusion criteria,...
3.
Fete M, Haight R, Clapp P, McCollum M
Am J Pharm Educ
. 2017 Jun;
81(4):68.
PMID: 28630509
To design and implement an instrument capable of providing students with valuable peer feedback on team behaviors and to provide results of the administration of the instrument. A three-part instrument...
4.
Clapp P, Calderon B, Sheridan L, Sucher B
Am J Pharm Educ
. 2014 Jun;
78(5):106.
PMID: 24954946
Objective: To design, implement, and evaluate a faculty development program intended to orient nonpharmacist faculty members to pharmacy practice. Design: A multifaceted program was implemented in 2012 that included 4...
5.
Wackernah R, Minnick M, Clapp P
Subst Abuse Rehabil
. 2014 Mar;
5:1-12.
PMID: 24648792
Alcohol use disorders (AUD) continue to be a concerning health issue worldwide. Harmful alcohol use leads to 2.5 million deaths annually worldwide. Multiple options exist for the management of dependence...
6.
Procopio D, Saba L, Walter H, Lesch O, Skala K, Schlaff G, et al.
Alcohol Clin Exp Res
. 2013 Jan;
37(6):896-904.
PMID: 23278386
Background: Alcohol dependence (AD) is often accompanied by comorbid depression. Recent clinical evidence supports the benefit of subtype-specific pharmacotherapy in treating the population of alcohol-dependent subjects with comorbid major depressive...
7.
Clapp P
Expert Rev Clin Pharmacol
. 2012 Sep;
5(4):427-35.
PMID: 22943122
Alcoholism is a progressive neurological disorder that represents one of the leading preventable causes of morbidity and mortality in the USA. Individuals with alcohol dependence may exhibit differences in their...
8.
Clapp P, Bhave S, Hoffman P
Alcohol Res Health
. 2010 Aug;
31(4):310-39.
PMID: 20729980
The development of alcohol dependence is posited to involve numerous changes in brain chemistry (i.e., neurotransmission) that lead to physiological signs of withdrawal upon abstinence from alcohol as well as...
9.
Clapp P, Gibson E, DellAcqua M, Hoffman P
J Pharmacol Exp Ther
. 2009 Dec;
332(3):720-9.
PMID: 20008487
Alterations in N-methyl-d-aspartate receptor (NMDAR) protein levels or subcellular localization in brain after chronic ethanol exposure may contribute to withdrawal-associated seizures and neurotoxicity. We have investigated synaptic localization of NMDARs...
10.
Clapp P, Capper A, Taussig R
Methods Enzymol
. 2001 Oct;
345:241-51.
PMID: 11665608
Initial steps in the identification of the Gs alpha-binding site present in mammalian adenylyl cyclases can be achieved with the use of the yeast genetic system described. It must be...